Offering coverage options of up to $10 million, this enhanced solution is tailored to address the specific risks faced by the life sciences industry.
The policy is designed to cater to various sectors, including biotechnology and specialty pharmaceutical manufacturers and distributors, producers of non-invasive, invasive, and permanently implantable medical devices, blood plasma manufacturers, as well as contract manufacturing and contract development manufacturing organisations (CMOs and CDMOs).
Marco Hensel, Chief Underwriting Officer at HDI Global Insurance Company, commented: “HDI is dedicated to providing our clients with bespoke solutions in the life sciences sector. The launch of our US Life Sciences division exemplifies HDI’s ongoing focus on growth in the region, as we continue to act as a true Partner in Transformation for our clients during this period of rapid medical innovation.”
Brian Carlsen has recently joined HDI as Assistant Vice President and will take on the role of US Life Science Lead, focusing on expanding the company’s business in this area. With 16 years of underwriting experience, including 10 years specialising in life sciences placements, Carlsen brings a wealth of knowledge to the position. Before joining HDI, he held the role of Underwriting Manager and Referral Underwriter for the East region at a Fortune 500 insurance carrier, and holds a degree in communications from Fairfield University.
Dani Maurer, Head of HDI’s Liability Global Risk Division, said: “We are thrilled to have Brian join our US casualty team. His extensive experience with life sciences firms, from start-ups to large multinational corporations, will be invaluable as we expand HDI’s product offering in the US market.”
